Rader: “The law makes no sense any more”
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Rader: “The law makes no sense any more”

Former Chief Judge of the Federal Circuit Randall Rader has said that recent Supreme Court decisions have left the United States so out of step with the rest of the world that legislative correction is needed


“The point is the law makes no sense any more, and when it makes no sense any more it has to be rewritten,” Rader said in an afternoon session on patent law yesterday at the AIPLA Annual Meeting. “Not in the House, but the Senate – the Republicans are coming!”

Rader said that he recently did something he had not done for a long time – he read a judicial opinion five times. It was the Australian Myriad judicial opinion.

“The Australian version of Myriad, not the American one, got it dead right,” said Rader. “United States law is the one that is out of tune.”

Rader appeared to suggest that the audience should consider how an appeal will affect the law before filing one. One audience member pushed him on this, saying a client may think settlement terms are unacceptable even if an appeal may change the law in a way it doesn’t like.

“What I’m telling you is if you bring Bilski to the Supreme Court you can expect the results you are going to get,” replied Rader.

“Therefore, if you are wise, you settle it before it gets there. Has that happened before? Yes. Dozens of times and that’s what this group can do strategically to get a good case so that there is good law.

“How well have you done with Bilski, Alice, Prometheus and Myriad? How do you propose we get from the US state of patent eligibility, which is out of step with the whole world, back in to harmony with international standards? I just told you – legislative correction.”

Rader said that given a case with the right characteristics, however, there is a chance for the law to be narrowed. “If you find the right case, there is room to narrow it,” he said.


Responding to some pessimistic audience comments about the effect the Supreme Court is having on innovation in the technology space, Bob Stoll, the session’s moderator, said: “I do think software is patentable and claiming it in a manner that is viable is still possible. But I think there are significant problems and we need to figure out a way to make sure it doesn’t deteriorate further and does in fact get better.”

He noted that the fact that a number of industries are being affected could give cause for hope that there will be change. “I do think we have a collective pain here where we have got all the emerging technologies under attack,” said Stoll. “It is rare we get the folks in the software creation industry in complete alignment with those in the biotech industry. The catalytic manufacturing industry is also going be impacted as are surgical devices.”

He continued: “I think you’re going to find a very strong group of companies and interests looking to fix this. If we decide to go in that direction, that would be very helpful for moving things on the Hill, because I do believe that Members of Congress and Senators listen to their constituents who come to talk to them. Patent subject matter eligibility hasn’t been at the forefront in Congress, but as it elevates there may be some interest in doing something.”

more from across site and ros bottom lb

More from across our site

Counsel say the USPTO's examples of AI patentability should make their lives easier and help point clients in the right direction
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Ehsun Forghany says he was impressed by the firm's focus on fashion and IP as well as the expertise of chairman Anthony Lupo
Counsel at medical device companies say the unitary patent, AI and terminal disclaimers are major areas of concern
The LMG Life Sciences Awards is thrilled to present the shortlist for the 2024 Ameicas Awards
Daniel Wise at Carpmaels & Ransford explains how he helped secure the first UPC revocation ruling on behalf of Sanofi and Regeneron against Amgen
Patent attorney Joanne van Harmelen reflects on how her move from full-service firm ENSafrica to IP outfit Adams & Adams has affected her practice
The EU should press ahead with plans to introduce a unitary SPC and the UPC and EUIPO should play leading roles, says Jörg Thomaier at Bayer
Lawyers reveal how they inform clients about the IP implications of fast-moving private equity deals
View the Social Impact EMEA Awards 2024 shortlist and join us on September 12 at The Waldorf Hotel in London
Gift this article